Instituto Do Câncer Do Estado de São Paulo Octávio Frias de Oliveira

São Paulo, São Paulo 01246 000

0 studies enrolling now · 2 studies all time

What they study most

Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] — Completed